Pro- and Anti-inflammatory Cytokines and Osteoclastogenesis-related Factors in Peri-implant Diseases: Systematic Review and Meta-analysis

Overview

Journal BMC Oral Health

Publisher Biomed Central

Specialty Dentistry

Date 2023 Jun 24

PMID 37355561

Authors

Jovania Alves Oliveira

Roberta de Oliveira Alves

Isabella Mazarelo Nascimento

Marco Antonio Rimachi Hidalgo

Raquel Mantuaneli Scarel-Caminaga

Suzane Cristina Pigossi

Affiliations

Soon will be listed here.

Abstract

Background: Pro- and anti-inflammatory cytokines are acknowledged, during inflammatory bone destruction, as key regulators of osteoclast and osteoblast differentiation and activity. However, evidence regarding the exact role of pro- and anti-inflammatory cytokines and osteoclastogenesis-related factors in peri-implant diseases is unclear. We aimed to execute a systematic review and meta-analysis about the pro- and anti-inflammatory cytokines and osteoclastogenesis-related factors levels in peri-implant diseases.

Methods: The focused question was elaborated to summarize the levels of pro-and anti-inflammatory cytokines and osteoclastogenesis-related factors in tissue samples (mRNA) and biofluids (protein levels) of patients with/without peri-implant diseases. Electronic searches of the PubMed, Cochrane Controlled Trials Registry, Web of Science, EMBASE, Scopus and Google scholar databases were conducted for publications up to March 2023. Meta-analysis evaluating the mediator´s levels (protein levels by ELISA) in peri-implant crevicular fluid (PICF) were made. The effect size was estimated and reported as the mean difference. The 95% confidence interval was estimated for each mediator, and the pooled effect was determined significant if two-sided p-values < 0.05 were obtained.

Results: Twenty-two publications were included in the systematic review (qualitative analysis), with nine of these subjected to meta-analyses (quantitative analysis). In the qualitative analysis, higher pro-inflammatory cytokines [Interleukin (IL)-1β, IL-6] and pro-osteoclastogenic mediator [Receptor Activator of Nuclear Factor-Kappa B ligand (RANKL)] levels were observed in PICF of individuals with peri-implant diseases in comparison to healthy individuals. Higher RANKL/osteoprotegerin (OPG) ratios were observed in PICF from individuals with peri-implant diseases in comparison to healthy individuals. Meta-analysis showed higher RANKL levels in diseased groups compared to controls.

Conclusions: The results showed that the levels of IL-1β, IL-6, IL-10, and RANKL/OPG are not balanced in peri-implant disease, suggesting that these mediators are involved in the host osteo-immunoinflammatory response related to peri-implantitis.

Citing Articles

Liu D, Chen J, Zhou J, Dai J, Qin H, Wan G Mater Today Bio. 2025; 31:101519.

PMID: 39990739 PMC: 11846932. DOI: 10.1016/j.mtbio.2025.101519.

Role of immune dysregulation in peri-implantitis.

Huang M, Wang C, Li P, Lu H, Li A, Xu S Front Immunol. 2024; 15:1466417.

PMID: 39555067 PMC: 11563827. DOI: 10.3389/fimmu.2024.1466417.

Topical Oxygen Therapy for Promoting Healing After Implant Placement Using Blue® M Gel: A Report of Two Cases.

Ansari J, Dodamani G, Nagral S, Ronad S, Pawar P Cureus. 2024; 16(7):e65258.

PMID: 39184738 PMC: 11342578. DOI: 10.7759/cureus.65258.

Preliminary Evaluation of Bioactive Collagen-Polyphenol Surface Nanolayers on Titanium Implants: An X-ray Photoelectron Spectroscopy and Bone Implant Study.

Morra M, Iviglia G, Cassinelli C, Sartori M, Cavazza L, Martini L J Funct Biomater. 2024; 15(7).

PMID: 39057292 PMC: 11278435. DOI: 10.3390/jfb15070170.

Quantification and Influence of IL-1β on Pain and Inflammatory Response after Placement of a Cement-Screw-Retained Restoration.

Arbelaez-Bonozo L, Maza-Solano S, Baus-Dominguez M, Gomez-Diaz R, Ruiz-de-Leon-Pacheco G, Torres-Lagares D J Clin Med. 2024; 13(6).

PMID: 38541894 PMC: 10971256. DOI: 10.3390/jcm13061669.

References

Escalona L, Mastromatteo-Alberga P, Correnti M . Cytokine and metalloproteinases in gingival fluid from patients with chronic periodontitis. Invest Clin. 2017; 57(2):131-142. View

Rakic M, Struillou X, Petkovic-Curcin A, Matic S, Canullo L, Sanz M . Estimation of bone loss biomarkers as a diagnostic tool for peri-implantitis. J Periodontol. 2014; 85(11):1566-74. DOI: 10.1902/jop.2014.140069. View

Fiorentino D, Zlotnik A, Mosmann T, Howard M, OGarra A . IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991; 147(11):3815-22. View

Garlet G . Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res. 2010; 89(12):1349-63. DOI: 10.1177/0022034510376402. View

Severino V, Beghini M, Araujo M, de Melo M, Miguel C, Rodrigues W . Expression of IL-6, IL-10, IL-17 and IL-33 in the peri-implant crevicular fluid of patients with peri-implant mucositis and peri-implantitis. Arch Oral Biol. 2016; 72:194-199. DOI: 10.1016/j.archoralbio.2016.08.021. View

Kwon A, Kwak B, Kim K, Ha J, Kim S, Bae S . Cytokine levels in febrile seizure patients: A systematic review and meta-analysis. Seizure. 2018; 59:5-10. DOI: 10.1016/j.seizure.2018.04.023. View

Song L, Jiang J, Li J, Zhou C, Chen Y, Lu H . The Characteristics of Microbiome and Cytokines in Healthy Implants and Peri-Implantitis of the Same Individuals. J Clin Med. 2022; 11(19). PMC: 9572122. DOI: 10.3390/jcm11195817. View

Tzach-Nahman R, Mizraji G, Shapira L, Nussbaum G, Wilensky A . Oral infection with Porphyromonas gingivalis induces peri-implantitis in a murine model: Evaluation of bone loss and the local inflammatory response. J Clin Periodontol. 2017; 44(7):739-748. DOI: 10.1111/jcpe.12735. View

Uyttenhove C, Coulie P, Van Snick J . T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. J Exp Med. 1988; 167(4):1417-27. PMC: 2188915. DOI: 10.1084/jem.167.4.1417. View

10.

Rakic M, Petkovic-Curcin A, Struillou X, Matic S, Stamatovic N, Vojvodic D . CD14 and TNFα single nucleotide polymorphisms are candidates for genetic biomarkers of peri-implantitis. Clin Oral Investig. 2014; 19(4):791-801. DOI: 10.1007/s00784-014-1313-3. View

11.

Fonseca F, Moraes Junior M, Lourenco E, Teles D, Figueredo C . Cytokines expression in saliva and peri-implant crevicular fluid of patients with peri-implant disease. Clin Oral Implants Res. 2012; 25(2):e68-72. DOI: 10.1111/clr.12052. View

12.

Kim S, Park J, Lee Y, Seo H, Sheen S, Hahn S . Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013; 66(4):408-14. DOI: 10.1016/j.jclinepi.2012.09.016. View

13.

Finoti L, Nepomuceno R, Pigossi S, Corbi S, Secolin R, Scarel-Caminaga R . Association between interleukin-8 levels and chronic periodontal disease: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2017; 96(22):e6932. PMC: 5459707. DOI: 10.1097/MD.0000000000006932. View

14.

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

15.

Fiorentino D, Zlotnik A, Mosmann T, Howard M, OGarra A . Pillars Article: IL-10 Inhibits Cytokine Production by Activated Macrophages. J. Immunol. 1991. 147: 3815-3822. J Immunol. 2016; 197(5):1539-46. View

16.

Berglundh T, Persson L, Klinge B . A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years. J Clin Periodontol. 2003; 29 Suppl 3:197-212; discussion 232-3. DOI: 10.1034/j.1600-051x.29.s3.12.x. View

17.

Ata-Ali J, Flichy-Fernandez A, Alegre-Domingo T, Ata-Ali F, Palacio J, Penarrocha-Diago M . Clinical, microbiological, and immunological aspects of healthy versus peri-implantitis tissue in full arch reconstruction patients: a prospective cross-sectional study. BMC Oral Health. 2015; 15:43. PMC: 4391105. DOI: 10.1186/s12903-015-0031-9. View

18.

Zhang F, Koyama Y, Sanuki R, Mitsui N, Suzuki N, Kimura A . IL-17A stimulates the expression of inflammatory cytokines via celecoxib-blocked prostaglandin in MC3T3-E1 cells. Arch Oral Biol. 2010; 55(9):679-88. DOI: 10.1016/j.archoralbio.2010.06.003. View

19.

Rakic M, Monje A, Radovanovic S, Petkovic-Curcin A, Vojvodic D, Tatic Z . Is the personalized approach the key to improve clinical diagnosis of peri-implant conditions? The role of bone markers. J Periodontol. 2019; 91(7):859-869. DOI: 10.1002/JPER.19-0283. View

20.

Moore K, OGarra A, de Waal Malefyt R, Vieira P, Mosmann T . Interleukin-10. Annu Rev Immunol. 1993; 11:165-90. DOI: 10.1146/annurev.iy.11.040193.001121. View